Pharmacokinetics of tilmicosin (Provitil powder and pulmotil liquid AC) oral formulations in chickens

Veterinary Research Communications

Volumn 31, Issue 4, 2007, Pages 477-485

  Abu Basha, E A ^a   Idkaidek, N M ^a   Al Shunnaq, A F ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Bioavailability; Chicken; HPLC; Pharmacokinetics; Tilmicosin

Indexed keywords

PROVITIL; PULMOTIL AC; TILMICOSIN; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHICKEN; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; SINGLE DRUG DOSE; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHICKENS; MACROLIDES; TYLOSIN;

GALLUS GALLUS;

EID: 33847053972     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-006-3543-6     Document Type: Article

References (31)

1. Blackall, P.J., Asakawa, T., Graydon, R.J., White, M., Adamson, M., Wade, L.K. and Lowe, L.B., 1995. In-vitro antibacterial properties of tilmicosin against Australian isolates of Pasteurella multocida and Actinobacillus pleuropneumoniae from pigs. Australian Veterinary Journal, 72, 35-36
2. Chen, M.L., Shah, V., Patnaik, R., Adams, W., Hussain, A., conner, D., Mehta, M., Malinowski, H., Lazor, J., Huang, S.M., Hare, D., Lesko, L., Sporn, D. and Williams, R., 2001. Bioavailability and bioequivalence: An FDA regulatory overview. Pharmceutical Research, 18, 1645-1650
3. Christodoulopoulos, G., Warnick, L.D., Papaioannou, N. and Fthenakis, G.C., 2002. Tilmicosin administration to young lambs with respiratory infection: Safety and efficacy considerations. Journal of Veterinary Pharmacology and Therapeutics, 25, 393-397
4. Clark, C., Woodbury, M., Dowling, P., Ross, S. and Boison, J.O., 2004. A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum. Journal of Veterinary Pharmacology and Therapeutics, 27, 385-387
5. DeRosa, D.C., Veenhuizen, M.F., Bade, D.J. and Shryock, T.R., 2000. In vitro susceptibility of porcine respiratory pathogens to tilmicosin. Journal of Veterinary Diagnostic Investigation, 2, 541-546
6. EMEA, 1998. (The European Agency for the Evaluation of Medicinal Products Veterinary Medicines Evaluation Unit) Committee for veterinary medicinal products. Tilmicosin (extension to chicken), summary report 2. http://www.emea.eu.int/pdfs/vet/mrls/039098en.pdf
7. Gibaldi, M. and Perrier, D., 1982. Pharmacokinetics. (Marcel Dekker, New York)
8. Hoar, B.R., Jelinski, M.D., Ribble, C.S., Janzen, E.D. and Johnson, J.C., 1998. A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada. Candian Veterinary Journal, 39, 161-166
9. Jordan, F.T. and Horrocks, B.K., 1996. The minimum inhibitory concentration of tilmicosin and tylosin for Mycoplasma gallisepticum and Mycoplasma synoviae and a comparison of their efficacy in the control of Mycoplasma gallisepticum infection in broiler chicks. Avian Diseases, 40, 326-334
10. Jordan, W.H., Byrd, R.A., Cochrane, R.L., Hanasono, G.K., Hoyt, J.A., and Main, B.W., 1993. Meyerhoff, R.D., and Sarazan, R.D. A review of the toxicology of the antibiotic MICOTIL 300. Veterinary and Human Toxicology, 35, 151-158
11. Juhel-Gaugain, M., Anger, B. and Laurentie, M.,1999. Multiresidue chromatographic method for the determination of macrolide residues in muscle by high-performance liquid chromatography with UV detection. Journal of AOAC International, 82, 1046-1053
12. Keles, O., Bakirel, T. and Sener, S., 2001. Pharmacokinetics and tissue levels of tilmicosin in fowls. Turkish Journal of Veterinary and Animal Sciences, 25, 629-634
13. Kempf, I., Reeve-Johnson, L., Gesbert, F. and Guittet, M., 1997. Efficacy of tilmicosin in the control of experimental Mycoplasma gallisepticum infection in chickens. Avian Diseases, 41, 802-807
14. Main, B.W., Means, J.R., Rinkema, L.E., Smith, W.C. and Sarazan, R.D., 1996. Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs. Journal of Veterinary Pharmacology and Therapeutics, 19, 225-232
15. Modric, S., Webb, A.I. and Derendorf, H., 1998. Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. Journal of Veterinary Pharmacology and Therapeutics, 21, 444-452
16. Modric, S., Webb, A.I. and Davidson, M., 1999. Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats. Laboratory Animal Science, 49, 248-253
17. Moore, G.M., Basson, R.P. and Tonkinson, L.V., 1996. Clinical field trials with tilmicosin phosphate in feed for the control of naturally acquired pneumonia caused by Actinobacillus pleuropneumoniae and Pasteurella multocida in swine. American Journal of Veterinary Research, 57, 224-228
18. Papich, M.G. and Riviere, J.E., 2001. Chloramphenicol and derivatives, macrolides, lincosamides and miscellaneous antimicrobials. Veterinary Pharmacology and Therapeutics, 8th edn (Iowa State Press, Ames, IA), 880-881
19. Prescott, J.F., 2000. Macrolides and pleuromyilins. Antimicrobial Therapy in Veterinary Medicine, 3rd edn (Iowa State University Press, Ames, IA), 229-262
20. Ramadan, A., 1997. Pharmacokinetics of tilmicosin in serum and milk of goats. Research in Veterinary Science, 62, 48-50
21. Salmon, S.A., Watts, J.L., Case, C.A., Hoffman, L.J., Wegener, H.C. and Yancey, R.J. Jr, 1995. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark. Journal of Clinical Microbiology, 33, 2435-2444
22. Shen, J., Li, C., Jiang, H., Zhang, S., Guo, P., Ding, S. and Li, X., 2005. Pharmacokinetics of tilmicosin after oral administration in swine. American Journal of Veterinary Research, 66, 1071-1074
23. Scorneaux, B. and Shryock, T.R., 1998a. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in chicken phagocytes. Poultry Science, 77, 1510-1521
24. Scorneaux, B. and Shryock, T.R., 1998b. Intracellular accumulation, subcellular distribution and efflux of tilmicosin in swine phagocytes. Journal of Veterinary Pharmacology and Therapeutics, 21, 257-268
25. Scorneaux, B. and Shryock, T.R., 1999. Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. Journal of Dairy Science, 82, 1202-1212
26. Toutain, P.L. and Bousquet-Melou, A., 2004. Bioavailability and its assessment. Journal of Veterinary Pharmacology and Therapeutics, 27, 455-466
27. Varga, J., Fodor, L. and Makrai, L., 2001. Characterisation of some Ornithobacterium rhinotracheale strains and examination of their transmission via eggs. Acta Veterinaria Hungarica, 49, 125-130
28. Vogel, G.J., Laudert, S.B., Zimmermann, A., Guthrie, C.A., Mechor, G.D. and Moore, G.M., 1998. Effects of tilmicosin on acute undifferentiated respiratory tract disease in newly arrived feedlot cattle. Journal of the American Veterinary Medical Association, 15, 1919-1924
29. Watkins, K.L., Shryock, T.R., Dearth, R.N. and Saif, Y.M, 1997. In-vitro antimicrobial susceptibility of Clostridium perfringens from commercial turkey and broiler chicken origin. Veterinary Microbiology, 54, 195-200.
30. Watts, J.L., 1999. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: approved standard (M31-A), NCCLS 19, no. 11.
31. Ziv, G., Shem-Tov, M., Glickman, A., Winkler, M. and Saran, A., 1995. Tilmicosin antibacterial activity and pharmacokinetics in cows. Journal of Veterinary Pharmacology and Therapeutics, 18, 340-345